{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:41:55Z","timestamp":1792093315961,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18CDA34110454"],"award-info":[{"award-number":["18CDA34110454"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["042652"],"award-info":[{"award-number":["042652"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficits in insulin signaling. Pre-clinical studies have shown that intranasal insulin is neuroprotective in models of Alzheimer\u2019s disease, Parkinson\u2019s disease, and traumatic brain injury. Clinical trials have also shown that intranasal insulin elicits beneficial cognitive effects in patients with Alzheimer\u2019s disease. It is known that insulin can be detected in the CNS within minutes following intranasal administration. Despite these advances, the anatomical pathways that insulin utilizes to reach the CNS and the cellular CNS targets after intranasal administration are not fully understood. Here, we intranasally administered fluorescently labeled insulin and imaged its localization within the brain and trigeminal nerves. Our data indicates that intranasal insulin can reach cellular CNS targets along extracellular components of the trigeminal nerve. Upon CNS entry, we found insulin significantly increased levels of an activated form of the insulin receptor. These findings suggest that the intranasal route of administration is able to effectively deliver insulin to CNS targets in a biologically active form.<\/jats:p>","DOI":"10.1038\/s41598-019-39191-5","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T06:03:34Z","timestamp":1550815414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Distribution of insulin in trigeminal nerve and brain after intranasal administration"],"prefix":"10.1038","volume":"9","author":[{"given":"Jeffrey J.","family":"Lochhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Kellohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ronaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"39191_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14, 168\u2013181, https:\/\/doi.org\/10.1038\/nrneurol.2017.185 (2018).","journal-title":"Nat Rev Neurol"},{"key":"39191_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145-146","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. Insulin resistance and Parkinson\u2019s disease: A new target for disease modification? Prog Neurobiol 145\u2013146, 98\u2013120, https:\/\/doi.org\/10.1016\/j.pneurobio.2016.10.001 (2016).","journal-title":"Prog Neurobiol"},{"key":"39191_CR3","doi-asserted-by":"publisher","unstructured":"Dodd, G. T. & Tiganis, T. Insulin action in the brain: Roles in energy and glucose homeostasis. J Neuroendocrinol 29, https:\/\/doi.org\/10.1111\/jne.12513 (2017).","DOI":"10.1111\/jne.12513"},{"key":"39191_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrendo.2015.173","volume":"11","author":"M Heni","year":"2015","unstructured":"Heni, M., Kullmann, S., Preissl, H., Fritsche, A. & Haring, H. U. Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11, 701\u2013711, https:\/\/doi.org\/10.1038\/nrendo.2015.173 (2015).","journal-title":"Nat Rev Endocrinol"},{"key":"39191_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12035-013-8404-z","volume":"47","author":"R Ghasemi","year":"2013","unstructured":"Ghasemi, R. et al. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol 47, 1045\u20131065, https:\/\/doi.org\/10.1007\/s12035-013-8404-z (2013).","journal-title":"Mol Neurobiol"},{"key":"39191_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00702-013-1147-1","volume":"121","author":"M Ramalingam","year":"2014","unstructured":"Ramalingam, M. & Kim, S. J. Mechanisms of action of brain insulin against neurodegenerative diseases. J Neural Transm (Vienna) 121, 611\u2013626, https:\/\/doi.org\/10.1007\/s00702-013-1147-1 (2014).","journal-title":"J Neural Transm (Vienna)"},{"key":"39191_CR7","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1177\/0271678X16685106","volume":"37","author":"F Brabazon","year":"2017","unstructured":"Brabazon, F. et al. Intranasal insulin treatment of an experimental model of moderate traumatic brain injury. J Cereb Blood Flow Metab 37, 3203\u20133218, https:\/\/doi.org\/10.1177\/0271678X16685106 (2017).","journal-title":"J Cereb Blood Flow Metab"},{"key":"39191_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejphar.2013.08.008","volume":"719","author":"B Cholerton","year":"2013","unstructured":"Cholerton, B., Baker, L. D. & Craft, S. Insulin, cognition, and dementia. Eur J Pharmacol 719, 170\u2013179, https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.008 (2013).","journal-title":"Eur J Pharmacol"},{"key":"39191_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12975-015-0409-7","volume":"6","author":"VA Lioutas","year":"2015","unstructured":"Lioutas, V. A. et al. Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res 6, 264\u2013275, https:\/\/doi.org\/10.1007\/s12975-015-0409-7 (2015).","journal-title":"Transl Stroke Res"},{"key":"39191_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2016.01.020","volume":"318","author":"Y Pang","year":"2016","unstructured":"Pang, Y. et al. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience 318, 157\u2013165, https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.020 (2016).","journal-title":"Neuroscience"},{"key":"39191_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/acel.12498","volume":"15","author":"YF Mao","year":"2016","unstructured":"Mao, Y. F. et al. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe\/PS1dE9 mice. Aging Cell 15, 893\u2013902, https:\/\/doi.org\/10.1111\/acel.12498 (2016).","journal-title":"Aging Cell"},{"key":"39191_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr, J. et al. Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs 27, 505\u2013514, https:\/\/doi.org\/10.1007\/s40263-013-0076-8 (2013).","journal-title":"CNS Drugs"},{"key":"39191_CR13","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict, C. et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29, 1326\u20131334, https:\/\/doi.org\/10.1016\/j.psyneuen.2004.04.003 (2004).","journal-title":"Psychoneuroendocrinology"},{"key":"39191_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft, S. et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69, 29\u201338, https:\/\/doi.org\/10.1001\/archneurol.2011.233 (2012).","journal-title":"Arch Neurol"},{"key":"39191_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead, J. J. & Thorne, R. G. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64, 614\u2013628, https:\/\/doi.org\/10.1016\/j.addr.2011.11.002 (2012).","journal-title":"Adv Drug Deliv Rev"},{"key":"39191_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","volume":"9","author":"K Drejer","year":"1992","unstructured":"Drejer, K. et al. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet Med 9, 335\u2013340 (1992).","journal-title":"Diabet Med"},{"key":"39191_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JAD-150307","volume":"47","author":"TS Salameh","year":"2015","unstructured":"Salameh, T. S. et al. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition. J Alzheimers Dis 47, 715\u2013728, https:\/\/doi.org\/10.3233\/JAD-150307 (2015).","journal-title":"J Alzheimers Dis"},{"key":"39191_CR18","doi-asserted-by":"publisher","unstructured":"Schmid, V. et al. Safety of intranasal human insulin: A review. Diabetes Obes Metab, https:\/\/doi.org\/10.1111\/dom.13279 (2018).","DOI":"10.1111\/dom.13279"},{"key":"39191_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acschemneuro.7b00434","volume":"9","author":"MT Nedelcovych","year":"2018","unstructured":"Nedelcovych, M. T. et al. Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse. ACS Chem Neurosci 9, 809\u2013816, https:\/\/doi.org\/10.1021\/acschemneuro.7b00434 (2018).","journal-title":"ACS Chem Neurosci"},{"key":"39191_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne, R. G., Pronk, G. J., Padmanabhan, V. & Frey, W. H. 2nd Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127, 481\u2013496, https:\/\/doi.org\/10.1016\/j.neuroscience.2004.05.029 (2004).","journal-title":"Neuroscience"},{"key":"39191_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","volume":"35","author":"JJ Lochhead","year":"2015","unstructured":"Lochhead, J. J., Wolak, D. J., Pizzo, M. E. & Thorne, R. G. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metab 35, 371\u2013381, https:\/\/doi.org\/10.1038\/jcbfm.2014.215 (2015).","journal-title":"J Cereb Blood Flow Metab"},{"key":"39191_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn849","volume":"5","author":"J Born","year":"2002","unstructured":"Born, J. et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5, 514\u2013516, https:\/\/doi.org\/10.1038\/nn849 (2002).","journal-title":"Nat Neurosci"},{"key":"39191_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JAD-161095","volume":"57","author":"EM Rhea","year":"2017","unstructured":"Rhea, E. M. et al. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition. J Alzheimers Dis 57, 241\u2013252, https:\/\/doi.org\/10.3233\/JAD-161095 (2017).","journal-title":"J Alzheimers Dis"},{"key":"39191_CR24","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/j.2042-7158.2012.01555.x","volume":"64","author":"DB Renner","year":"2012","unstructured":"Renner, D. B. et al. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol 64, 1709\u20131714, https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01555.x (2012).","journal-title":"J Pharm Pharmacol"},{"key":"39191_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jneumeth.2011.01.029","volume":"197","author":"N Spitzer","year":"2011","unstructured":"Spitzer, N., Sammons, G. S. & Price, E. M. Autofluorescent cells in rat brain can be convincing impostors in green fluorescent reporter studies. J Neurosci Methods 197, 48\u201355, https:\/\/doi.org\/10.1016\/j.jneumeth.2011.01.029 (2011).","journal-title":"J Neurosci Methods"},{"key":"39191_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","volume":"16","author":"L Plum","year":"2005","unstructured":"Plum, L., Schubert, M. & Bruning, J. C. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16, 59\u201365, https:\/\/doi.org\/10.1016\/j.tem.2005.01.008 (2005).","journal-title":"Trends Endocrinol Metab"},{"key":"39191_CR27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1159\/000356582","volume":"32","author":"A Tsuchiya","year":"2013","unstructured":"Tsuchiya, A., Kanno, T. & Nishizaki, T. Stearic acid serves as a potent inhibitor of protein tyrosine phosphatase 1B. Cell Physiol Biochem 32, 1451\u20131459, https:\/\/doi.org\/10.1159\/000356582 (2013).","journal-title":"Cell Physiol Biochem"},{"key":"39191_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1254\/jphs.14182FP","volume":"126","author":"A Tsuchiya","year":"2014","unstructured":"Tsuchiya, A., Nagaya, H., Kanno, T. & Nishizaki, T. Oleic acid stimulates glucose uptake into adipocytes by enhancing insulin receptor signaling. J Pharmacol Sci 126, 337\u2013343, https:\/\/doi.org\/10.1254\/jphs.14182FP (2014).","journal-title":"J Pharmacol Sci"},{"key":"39191_CR29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/bi4016567","volume":"53","author":"MC Carpenter","year":"2014","unstructured":"Carpenter, M. C. & Wilcox, D. E. Thermodynamics of formation of the insulin hexamer: metal-stabilized proton-coupled assembly of quaternary structure. Biochemistry 53, 1296\u20131301, https:\/\/doi.org\/10.1021\/bi4016567 (2014).","journal-title":"Biochemistry"},{"key":"39191_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.xphs.2016.01.003","volume":"105","author":"CF Hjorth","year":"2016","unstructured":"Hjorth, C. F. et al. Structure, Aggregation, and Activity of a Covalent Insulin Dimer Formed During Storage of Neutral Formulation of Human Insulin. J Pharm Sci 105, 1376\u20131386, https:\/\/doi.org\/10.1016\/j.xphs.2016.01.003 (2016).","journal-title":"J Pharm Sci"},{"key":"39191_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7, 27\u201331, https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J Basic Clin Pharm"},{"key":"39191_CR32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0196-9781(97)00198-8","volume":"18","author":"WA Banks","year":"1997","unstructured":"Banks, W. A., Jaspan, J. B. & Kastin, A. J. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18, 1257\u20131262 (1997).","journal-title":"Peptides"},{"key":"39191_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2337\/diab.35.2.246","volume":"35","author":"DG Baskin","year":"1986","unstructured":"Baskin, D. G. et al. Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes 35, 246\u2013249 (1986).","journal-title":"Diabetes"},{"key":"39191_CR34","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1007\/s00125-017-4285-4","volume":"60","author":"SM Gray","year":"2017","unstructured":"Gray, S. M., Aylor, K. W. & Barrett, E. J. Unravelling the regulation of insulin transport across the brain endothelial cell. Diabetologia 60, 1512\u20131521, https:\/\/doi.org\/10.1007\/s00125-017-4285-4 (2017).","journal-title":"Diabetologia"},{"key":"39191_CR35","doi-asserted-by":"publisher","unstructured":"Hersom, M. et al. The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells, but does not mediate insulin entry from blood-to-brain. Am J Physiol Endocrinol Metab, https:\/\/doi.org\/10.1152\/ajpendo.00350.2016 (2018).","DOI":"10.1152\/ajpendo.00350.2016"},{"key":"39191_CR36","doi-asserted-by":"publisher","first-page":"E8478","DOI":"10.1073\/pnas.1710625114","volume":"114","author":"M Konishi","year":"2017","unstructured":"Konishi, M. et al. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci USA 114, E8478\u2013E8487, https:\/\/doi.org\/10.1073\/pnas.1710625114 (2017).","journal-title":"Proc Natl Acad Sci USA"},{"key":"39191_CR37","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1113\/JP276149","volume":"596","author":"EM Rhea","year":"2018","unstructured":"Rhea, E. M., Rask-Madsen, C. & Banks, W. A. Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol 596, 4753\u20134765, https:\/\/doi.org\/10.1113\/JP276149 (2018).","journal-title":"J Physiol"},{"key":"39191_CR38","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4, 147ra111, https:\/\/doi.org\/10.1126\/scitranslmed.3003748 (2012).","journal-title":"Sci Transl Med"},{"key":"39191_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1113\/JP275105","volume":"596","author":"ME Pizzo","year":"2018","unstructured":"Pizzo, M. E. et al. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery. J Physiol 596, 445\u2013475, https:\/\/doi.org\/10.1113\/JP275105 (2018).","journal-title":"J Physiol"},{"key":"39191_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks, W. A., Owen, J. B. & Erickson, M. A. Insulin in the brain: there and back again. Pharmacol Ther 136, 82\u201393, https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006 (2012).","journal-title":"Pharmacol Ther"},{"key":"39191_CR41","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff, J. J. et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34, 16180\u201316193, https:\/\/doi.org\/10.1523\/JNEUROSCI.3020-14.2014 (2014).","journal-title":"J Neurosci"},{"key":"39191_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress, B. T. et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76, 845\u2013861, https:\/\/doi.org\/10.1002\/ana.24271 (2014).","journal-title":"Ann Neurol"},{"key":"39191_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng, W. et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 93, 215\u2013225, https:\/\/doi.org\/10.1016\/j.nbd.2016.05.015 (2016).","journal-title":"Neurobiol Dis"},{"key":"39191_CR44","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1523\/JNEUROSCI.2112-16.2017","volume":"37","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Focal Solute Trapping and Global Glymphatic Pathway Impairment in a Murine Model of Multiple Microinfarcts. J Neurosci 37, 2870\u20132877, https:\/\/doi.org\/10.1523\/JNEUROSCI.2112-16.2017 (2017).","journal-title":"J Neurosci"},{"key":"39191_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jneumeth.2008.05.003","volume":"172","author":"GM Aldridge","year":"2008","unstructured":"Aldridge, G. M., Podrebarac, D. M., Greenough, W. T. & Weiler, I. J. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172, 250\u2013254, https:\/\/doi.org\/10.1016\/j.jneumeth.2008.05.003 (2008).","journal-title":"J Neurosci Methods"},{"key":"39191_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mce.2018.01.015","volume":"473","author":"ZZ Kirshner","year":"2018","unstructured":"Kirshner, Z. Z. & Gibbs, R. B. Use of the REVERT((R)) total protein stain as a loading control demonstrates significant benefits over the use of housekeeping proteins when analyzing brain homogenates by Western blot: An analysis of samples representing different gonadal hormone states. Mol Cell Endocrinol 473, 156\u2013165, https:\/\/doi.org\/10.1016\/j.mce.2018.01.015 (2018).","journal-title":"Mol Cell Endocrinol"},{"key":"39191_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0065-2571(92)90014-Q","volume":"32","author":"M Alexander-Bridges","year":"1992","unstructured":"Alexander-Bridges, M. et al. Multiple insulin-responsive elements regulate transcription of the GAPDH gene. Adv Enzyme Regul 32, 149\u2013159 (1992).","journal-title":"Adv Enzyme Regul"},{"key":"39191_CR48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0026-0495(80)90200-0","volume":"29","author":"ML McDaniel","year":"1980","unstructured":"McDaniel, M. L. et al. Temporal changes in islet polymerized and depolymerized tubulin during biphasic insulin release. Metabolism 29, 762\u2013766 (1980).","journal-title":"Metabolism"},{"key":"39191_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/0014-4827(92)90206-N","volume":"200","author":"JL Messina","year":"1992","unstructured":"Messina, J. L. & Weinstock, R. S. Regulation of beta-actin gene transcription by insulin and phorbol esters. Exp Cell Res 200, 532\u2013535 (1992).","journal-title":"Exp Cell Res"},{"key":"39191_CR50","doi-asserted-by":"crossref","unstructured":"Tsakiridis, T. et al. Role of the actin cytoskeleton in insulin action. Microsc Res Tech 47, 79\u201392, 10.1002\/(SICI)1097-0029(19991015)47:2 79::AID-JEMT1 3.0.CO;2-S (1999).","DOI":"10.1002\/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S"},{"key":"39191_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0169-328X(92)90212-T","volume":"13","author":"C Wang","year":"1992","unstructured":"Wang, C., Li, Y., Wible, B., Angelides, K. J. & Ishii, D. N. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 13, 289\u2013300 (1992).","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39191-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:17:56Z","timestamp":1671239876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39191-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2621"}}